Kidney Disease Awareness and Early Detection

Our Policy Positions and Advocacy Actions

Screening for Kidney Disease

The National Kidney Foundation urges those at risk to visit their health care provider or a local community health center to get a simple test to check for kidney damage. The risks for kidney disease include:

  • High blood pressure
  • Diabetes
  • Being over age 60
  • A family history of kidney failure

Promoting Early Detection in Federal Health Programs

The National Kidney Foundation advocates for Medicare, Medicaid, and health plans participating in the Affordable Care Act’s health insurance marketplaces to educate and encourage primary care practitioners to improve earlier detection, diagnosis, and management of kidney disease.

Latest Kidney Disease Awareness and Early Detection Updates

9/10/18 - The National Kidney Foundation submitted comments to CMS on the CY2019 Physician Fee Schedule proposed rule. Read the full comments (pdf).

4/26/18 - NKF submitted testimony to the House Appropriations Committee's Subcommittees on Labor, HHS, Education, and Related Agencies regarding the impact of Chronic Kidney Disease (CKD), and programs Congress can further support at the National Institutes of Health, Centers for Disease Control, and Health Resources and Services Administration to improve the treatment of CKD. Read the full testimony (pdf).

3/2/18—3/2/18 - The National Kidney Foundation submitted comments to CMS on several proposed changes to how the agency calculates payments to Medicare Advantage and Part D plans. These changes will impact CKD and ESRD patients access to these plans and the benefits they receive. Read the full comments (pdf).

1/19/18 — National Kidney Foundation recommends new payment model to improve earlier detection and treatment of people with chronic kidney disease. Read the full comments (pdf).

8/22/17 — NKF submitted comments to CMS on the proposed rule for CY 2018 Updates to the Quality Payment Program (QPP). Read the full testimony (pdf).

3/9/17 — NKF submitted testimony to the House Appropriations Committee's Subcommittees on Labor, HHS, Education, and Related Agencies regarding the impact of Chronic Kidney Disease (CKD), and programs Congress can further support at the National Institutes of Health, Centers for Disease Control, and Health Resources and Services Administration to improve early detection and treatment of the disease. Read the full testimony (pdf).

8/26/16 — NKF submitted comments to CMS on the proposed rule, CMS-1651-P, regarding the care of patients with Chronic Kidney Disease (CKD) and Alternative Payment Models (APMs) and Advanced Alternative Payment Models (AAPMS). Read the full NKF Comments (pdf).

6/28/16 — NKF's comments on the recent proposed rule from the Centers for Medicare & Medicaid Services (CMS) implementing value based purchasing components of the Medicare Access and CHIP Reauthorization Act of 2015 (MACRA). Full NKF Comments.

4/15/16 — NKF submitted testimony to the Senate and House Appropriations Committee’s Subcommittees on Labor, HHS, Education, and Related Agencies regarding the impact of Chronic Kidney Disease (CKD), and steps that can be taken by Congress to build upon the success of the existing programs at the National Institutes of Health, Centers for Disease Control, and Health Resources and Services Administration to improve early detection and treatment of the disease. Testimony to the Senate (.pdf) / House (.pdf)

3/2/16 — NKF comments on the new CMS Measure Development plan and encourages the agency to prioritize developing quality measures to detect and manage kidney disease earlier. Full NKF Comments.

1/29/16 — NKF advises Senate Finance Committee’s Chronic Care Working Group to move forward with improvements in the care of dialysis patients, but strongly urges the working group to improve earlier detection and care for those with CKD whose kidneys have not yet failed. Full NKF Comments.

2015 (click to expand)